Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Hude

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Vnitrni Lekarstvi|March 11, 2006
[Does G8002A polymorphism in endothelin gene have a meaning for other risks at the patients with heart failure?]L Spinarová, J Spinar, A Vasků, et al.
Physiological Research|October 24, 2007
Contribution to the V-V interval optimization in patients with cardiac resynchronization therapyM Novák, J Lipoldová, J Meluzín, et al.
Bratislavske Lekarske Listy|December 30, 2021
Effect of immunosuppressive therapy in inflammatory cardiomyopathy: data from The Czech Inflammatory Cardiomyopathy Immunosuppressive TrialH Poloczkova, J Krejci, P Hude, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Vnitrni Lekarstvi|March 11, 2006
[Does G8002A polymorphism in endothelin gene have a meaning for other risks at the patients with heart failure?]L Spinarová, J Spinar, A Vasků, et al.
Physiological Research|October 24, 2007
Contribution to the V-V interval optimization in patients with cardiac resynchronization therapyM Novák, J Lipoldová, J Meluzín, et al.
Bratislavske Lekarske Listy|December 30, 2021
Effect of immunosuppressive therapy in inflammatory cardiomyopathy: data from The Czech Inflammatory Cardiomyopathy Immunosuppressive TrialH Poloczkova, J Krejci, P Hude, et al.
Pageof 2